In addition, the REIT has earned itself a stellar reputation within the life science industry, establishing itself as the preferred brand tenants look to in terms of providing complex laboratory infrastructure and excellence in operations to the industry’s most innovative companies.
Alexandria Real Estate Equities (ARE) is an S&P 500 investment-grade REIT that focuses on niche life science real estate. It acquires, manages, expands and develops mainly office and laboratory space properties. The company leases its properties to pharmaceutical, biotechnology, diagnostic and personal care products companies, research institutions, and related government agencies.
There are several key positives to ARE. First, the healthcare industry, which the REIT caters to, is one that has long-term growth potential and is deemed an essential service in times of emergencies such as the Covid-19 pandemic.
